Safety Escalating Repeat IV, in Stroke Patients "MAG111539"

Completed

Phase 2 Results

Main Contacts

Name Phone E-mail
GSK Clinical Trials Study Director

Other Locations

Name City State Country Status
GSK Investigational Site Ulm Baden-Wuerttemberg Germany Unknown_status_icon
GSK Investigational Site Hannover Niedersachsen Germany Unknown_status_icon
GSK Investigational Site Portland Oregon United States Unknown_status_icon
GSK Investigational Site Essen Nordrhein-Westfalen Germany Unknown_status_icon
GSK Investigational Site Toronto Ontario Canada Unknown_status_icon
GSK Investigational Site Leipzig Sachsen Germany Unknown_status_icon
GSK Investigational Site Mainz Rheinland-Pfalz Germany Unknown_status_icon
GSK Investigational Site Los Angeles California United States Unknown_status_icon
GSK Investigational Site Orange California United States Unknown_status_icon
GSK Investigational Site Fort Collins Colorado United States Unknown_status_icon
GSK Investigational Site Detroit Michigan United States Unknown_status_icon
GSK Investigational Site Montreal Quebec Canada Unknown_status_icon
GSK Investigational Site Celle Niedersachsen Germany Unknown_status_icon
GSK Investigational Site Los Angeles California United States Unknown_status_icon
GSK Investigational Site Wiesbaden Hessen Germany Unknown_status_icon
GSK Investigational Site Koeln Nordrhein-Westfalen Germany Unknown_status_icon